Martin Sebastian
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Molecular Biology top 5%
- Immunology top 2%
- Cancer Research top 2%
- Co-authors
- Tony MokVassiliki A. PapadimitrakopoulouSuresh S. RamalingamYi‐Long WuWillemijn S.M.E. TheelenMyung‐Ju AhnFrances A. ShepherdHelen Mann
- Topics
- Lung Cancer Treatments and Mutations (67 papers)Lung Cancer Research Studies (37 papers)Colorectal Cancer Treatments and Studies (22 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Martin Sebastian
101 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 4.1k
- Pulmonary and Respiratory Medicine 3.3k
- Molecular Biology 1.7k
- Immunology 945
- Cancer Research 930
Countries citing papers authored by Martin Sebastian
This map shows the geographic impact of Martin Sebastian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Sebastian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Sebastian more than expected).
Fields of papers citing papers by Martin Sebastian
This network shows the impact of papers produced by Martin Sebastian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Sebastian. The network helps show where Martin Sebastian may publish in the future.
Co-authorship network of co-authors of Martin Sebastian
This figure shows the co-authorship network connecting the top 25 collaborators of Martin Sebastian. A scholar is included among the top collaborators of Martin Sebastian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Sebastian. Martin Sebastian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 3 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 2 | |
| 12 | 57 | |
| 13 | 0 | |
| 14 | 6 | |
| 15 | 39 | |
| 16 | Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trialbreakdown → | 500 |
| 17 | 19 | |
| 18 | 45 | |
| 19 | 44 | |
| 20 | 14 |
About Martin Sebastian
Martin Sebastian is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 117 papers that have together received 5.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (67 papers), Lung Cancer Research Studies (37 papers) and Colorectal Cancer Treatments and Studies (22 papers). The work is most often cited by research in Oncology (4.1k citations), Pulmonary and Respiratory Medicine (3.3k citations) and Cancer Research (930 citations). Martin Sebastian has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Tony Mok, Vassiliki A. Papadimitrakopoulou, Suresh S. Ramalingam, Yi‐Long Wu, Willemijn S.M.E. Theelen, Myung‐Ju Ahn, Frances A. Shepherd, Helen Mann, Hiroaki Akamatsu and Yong He. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.